🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 67080M103
- Market Cap
- Large Cap · $1 Billion
- IPO
- 7/23/2020 · $19.00/share
Business: Nurix Therapeutics, Inc. discovers drugs that harness the body’s natural process to control protein levels. The Company’s focus is on developing targeted therapies to treat cancer including novel, small molecule immuno-oncology agents.
Company Contact
- CEO
- Arthur T. Sands
- CFO
- Hans van Houte
- Headquarters
- 1700 Owens Street, Suite 205, San Francisco, CA 94158
- Phone
- 415-660-5320
- Investor Relations
- Janhavi Mohite, Stern IR · 212-362-1200 · janhavi.mohite@sternir.com